Table 1

Characteristics of the study population at the time of ultrasound assessment by TPA category

No plaques
N=90
Mild atherosclerosis
N=39
Moderate atherosclerosis
N=65
Severe atherosclerosis
N=41
p Value
Age49.2±10.955.8±11.657.9±8.364.3±9.2<0.0001
Sex: male48 (53.3%)14 (35.9%)40 (61.5%)31 (75.6%)0.01
Race: caucasian80 (88.9%)35 (89.7%)58 (89.2%)37 (90.2%)0.84
Duration of psoriasis (years)24.5±11.831±14.227.1±13.928.5±14.80.07
Duration of PsA (years)14.9±12.415.3±10.317.3±10.618±130.11
Smoking: ever37 (41.1%)16 (41.0%)29 (44.6%)29 (70.7%)0.008
Diabetes3 (3.3%)5 (12.8%)12 (18.5%)12 (29.3%)<0.0001
Hypertension53 (58.9%)24 (61.5%)50 (76.9%)34 (82.9%)0.001
Dyslipidaemia26 (28.9%)22 (56.4%)42 (64.6%)28 (68.3%)<0.0001
BMI (kg/m2)27.9±627.9±5.429.7±5.830.2±4.40.01
NSAIDs ever80 (88.9%)35 (89.7%)61 (93.9%)39 (95.1%)0.16
DMARDs ever80 (88.9%)36 (92.3%)58 (89.2%)34 (82.9%)0.42
Biological agents ever45 (50%)18 (40.2%)38 (58.8%)19 (46.3%)0.83
  • Bold type indicates a significant association (p<0.05).

  • BMI, body mass index; DMARDs, disease-modifying antirheumatic drugs; NSAIDs, non-steroidal anti-inflammatory drugs; PsA, psoriatic arthritis; TPA, total plaque area.